| pubmed-article:14564315 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:14564315 | lifeskim:mentions | umls-concept:C0035173 | lld:lifeskim |
| pubmed-article:14564315 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:14564315 | lifeskim:mentions | umls-concept:C0948089 | lld:lifeskim |
| pubmed-article:14564315 | lifeskim:mentions | umls-concept:C0016011 | lld:lifeskim |
| pubmed-article:14564315 | lifeskim:mentions | umls-concept:C0206460 | lld:lifeskim |
| pubmed-article:14564315 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:14564315 | lifeskim:mentions | umls-concept:C1538983 | lld:lifeskim |
| pubmed-article:14564315 | lifeskim:mentions | umls-concept:C0243076 | lld:lifeskim |
| pubmed-article:14564315 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:14564315 | lifeskim:mentions | umls-concept:C0015737 | lld:lifeskim |
| pubmed-article:14564315 | lifeskim:mentions | umls-concept:C0205088 | lld:lifeskim |
| pubmed-article:14564315 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:14564315 | pubmed:dateCreated | 2003-10-17 | lld:pubmed |
| pubmed-article:14564315 | pubmed:abstractText | In high-risk patients with acute coronary syndromes (ACS), there have been concerns relating to the safety of using low molecular weight heparins (LMWH) in combination with a glycoprotein (GP) IIb/IIIa antagonist, and the continued use of LMWH in patients brought to the cardiac catheterization laboratory for percutaneous coronary intervention (PCI). | lld:pubmed |
| pubmed-article:14564315 | pubmed:language | eng | lld:pubmed |
| pubmed-article:14564315 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14564315 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:14564315 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14564315 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14564315 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14564315 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14564315 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14564315 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14564315 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14564315 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14564315 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14564315 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14564315 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14564315 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14564315 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14564315 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:14564315 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:14564315 | pubmed:issn | 1097-6744 | lld:pubmed |
| pubmed-article:14564315 | pubmed:author | pubmed-author:HarringtonRob... | lld:pubmed |
| pubmed-article:14564315 | pubmed:author | pubmed-author:CohenMarcM | lld:pubmed |
| pubmed-article:14564315 | pubmed:author | pubmed-author:AntmanElliott... | lld:pubmed |
| pubmed-article:14564315 | pubmed:author | pubmed-author:EveryNathan... | lld:pubmed |
| pubmed-article:14564315 | pubmed:author | pubmed-author:BatesEric RER | lld:pubmed |
| pubmed-article:14564315 | pubmed:author | pubmed-author:PepineCarl... | lld:pubmed |
| pubmed-article:14564315 | pubmed:author | pubmed-author:TherouxPierre... | lld:pubmed |
| pubmed-article:14564315 | pubmed:author | pubmed-author:FergusonJames... | lld:pubmed |
| pubmed-article:14564315 | pubmed:author | pubmed-author:NICE-3... | lld:pubmed |
| pubmed-article:14564315 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:14564315 | pubmed:volume | 146 | lld:pubmed |
| pubmed-article:14564315 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:14564315 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:14564315 | pubmed:pagination | 628-34 | lld:pubmed |
| pubmed-article:14564315 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
| pubmed-article:14564315 | pubmed:meshHeading | pubmed-meshheading:14564315... | lld:pubmed |
| pubmed-article:14564315 | pubmed:meshHeading | pubmed-meshheading:14564315... | lld:pubmed |
| pubmed-article:14564315 | pubmed:meshHeading | pubmed-meshheading:14564315... | lld:pubmed |
| pubmed-article:14564315 | pubmed:meshHeading | pubmed-meshheading:14564315... | lld:pubmed |
| pubmed-article:14564315 | pubmed:meshHeading | pubmed-meshheading:14564315... | lld:pubmed |
| pubmed-article:14564315 | pubmed:meshHeading | pubmed-meshheading:14564315... | lld:pubmed |
| pubmed-article:14564315 | pubmed:meshHeading | pubmed-meshheading:14564315... | lld:pubmed |
| pubmed-article:14564315 | pubmed:meshHeading | pubmed-meshheading:14564315... | lld:pubmed |
| pubmed-article:14564315 | pubmed:meshHeading | pubmed-meshheading:14564315... | lld:pubmed |
| pubmed-article:14564315 | pubmed:meshHeading | pubmed-meshheading:14564315... | lld:pubmed |
| pubmed-article:14564315 | pubmed:meshHeading | pubmed-meshheading:14564315... | lld:pubmed |
| pubmed-article:14564315 | pubmed:meshHeading | pubmed-meshheading:14564315... | lld:pubmed |
| pubmed-article:14564315 | pubmed:meshHeading | pubmed-meshheading:14564315... | lld:pubmed |
| pubmed-article:14564315 | pubmed:meshHeading | pubmed-meshheading:14564315... | lld:pubmed |
| pubmed-article:14564315 | pubmed:meshHeading | pubmed-meshheading:14564315... | lld:pubmed |
| pubmed-article:14564315 | pubmed:meshHeading | pubmed-meshheading:14564315... | lld:pubmed |
| pubmed-article:14564315 | pubmed:meshHeading | pubmed-meshheading:14564315... | lld:pubmed |
| pubmed-article:14564315 | pubmed:meshHeading | pubmed-meshheading:14564315... | lld:pubmed |
| pubmed-article:14564315 | pubmed:meshHeading | pubmed-meshheading:14564315... | lld:pubmed |
| pubmed-article:14564315 | pubmed:meshHeading | pubmed-meshheading:14564315... | lld:pubmed |
| pubmed-article:14564315 | pubmed:meshHeading | pubmed-meshheading:14564315... | lld:pubmed |
| pubmed-article:14564315 | pubmed:meshHeading | pubmed-meshheading:14564315... | lld:pubmed |
| pubmed-article:14564315 | pubmed:meshHeading | pubmed-meshheading:14564315... | lld:pubmed |
| pubmed-article:14564315 | pubmed:year | 2003 | lld:pubmed |
| pubmed-article:14564315 | pubmed:articleTitle | Combining enoxaparin and glycoprotein IIb/IIIa antagonists for the treatment of acute coronary syndromes: final results of the National Investigators Collaborating on Enoxaparin-3 (NICE-3) study. | lld:pubmed |
| pubmed-article:14564315 | pubmed:affiliation | Cardiology Research 1-191, St Luke's Episcopal Hospital, Houston, Tex 77225, USA. jferguson@heart.thi.tmc.edu | lld:pubmed |
| pubmed-article:14564315 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:14564315 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:14564315 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14564315 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14564315 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14564315 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14564315 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14564315 | lld:pubmed |
